IsoRay (ISR) Reports Q3 Loss of $0.02/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to IsoRay (ISR) Reports Q3 Loss of $0.02/Share

IsoRay Announces Third Quarter Fiscal 2016 Financial Results and Early Conclusions from Ongoing Strategic Review Process

May 10, 2016 4:07 PM EDT

RICHLAND, Wash., May 10, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced its financial results for the third quarter and nine months of fiscal 2016, ended March 31, 2016.

Revenue was $1.2 million for the third quarter of fiscal 2016, ended March 31, 2016, a 3.5% increase compared to $1.16 million for the third quarter of fiscal 2015, ended March 31, 2015. Prostate brachytherapy represented 87% and 86%... More